Autonomous Therapeutics Competitors and Similar CompaniesClear all
Autonomous Therapeutics's competitors and similar companies include Bluebird Bio, Sarepta Therapeutics and SpliceBio.
 Autonomous Therapeutics Autonomous Therapeutics is a synthetic immunology company that develops artificial immune systems. |  Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases. |  SpliceBio SpliceBio (formerly known as ProteoDesign) is a biotechnology company developing gene therapies. | ||
Founding Date | Founding Date 2017 | Founding Date 1992 | Founding Date 1980 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Rockville, US HQ | Locations Somerville, US HQ | Locations Cambridge, US HQ Dublin, IE Zug, CH Providence, US | Locations Barcelona, ES HQ |
Employees | Employees 176% increase | Employees 32338% decrease | Employees 1,31413% increase | Employees 452% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 95.4 m | Valuation ($) 12.4 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $83.8m (FY, 2024) | Revenue (est.) $2.2b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $89.4m (FY, 2024) | Cost of goods $25.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ($5.6m) (FY, 2024) | Gross profit $2.2b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($240.7m) (FY, 2024) | Net income ($713.4m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 409m | Total funding raised N/A | Total funding raised $ 2m |
For sources of this data, please see the company profile
View Company Profiles
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View companySarepta Therapeutics
HQ
Cambridge, US
Employees
1,314↑ 13% increase
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
View companySpliceBio
HQ
Barcelona, ES
Employees
45↓ 2% decrease
SpliceBio (formerly known as ProteoDesign) is a biotechnology company developing gene therapies.
View company